baber/WOPTO huggingface dataset:
Patent RO-137425-A0 (RO)
Title: Automatic fire alarm system
Inventor: DRUGĂ CORIN-MIHAI
IPC: H02B13/025
Filed: 2022-07-18
Abstract: The invention relates to an automatic fire alarm system meant to equip closed electrical switchboards and to protect them against incipient fire. According to the invention, the system comprises: an electrical switchboard (1), a system (2) for fire detection and extinguishing provided with at least one specialized fire detection sensor (8) and a fire extinguishing system (9), a number of three-phase final consumers (3), a number of single-phase final consumers (4), an sound warning system (5), a light warning system (6) and an automatic system (7) for alarming decision-makers of successive hierarchical levels, where the automatic system (7), once activated by the sensor (8), successively alarms, for example via a GSM communicator, by means of messages mi={m1; m2; ...; mn}, memorized in a predefined reconfigurable list, at time intervals Δ ti={ Δ t1; Δ t2; ...; Δ tn}, also memorized in a predefined reconfigurable list, some decision-makers Ri={R1; R2; ... Rn} of successive hierarchical levels, also memorized in a predefined reconfigurable list, where a decision-maker Ri will have, starting from the moment of receiving the message mi, a time Δ ti to take notice of the occurring situation and to take action in order to extinguish the fire and to operate a button (11) which interrupts the action of the warning system (7), otherwise the decision-maker in charge situated on the next higher hierarchical level in the list is to be alarmed.
Patent AP-2004003112-A0 (AP)
Title: Formulations of atorvastatin stabilised with alkali metal additions
Inventor: SINGH ROMI BHARAT
IPC: A61K9/20
Filed: 2003-02-14
Abstract: A pharmaceutical formulation having improved bioavailability and bioequivalence includes particles of amorphous and/or crystalline atorvastatin that have a particle size (d90) less than 150 m and a mean panicle size (d50) of the atorvastatin particles that is between approximately 5 and 50 m. The atorvastatin can be one or more of atorvastatin calcium, atorvastatin magnesium, atorvastatin aluminum, atorvastatin iron, and atorvastatin zinc. The formulations of atorvastatin can be stabilized by mixing atorvastatin with an alkali metal salt additive at between approximately 1.2% and less than 5% w/w of the formulation. The alkali metal salt additive may be one or more of sodium carbonate, sodium bicarbonate, sodium hydroxide, sodium silicate, disodium hydrogen orthophosphate, sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium phosphate, sodium alutninate, cai-cmiii c<abonate, calcium hydroxide, magnesium carbonic, magnesium hydroxide, magnesium iiliciiU;, rr.cigr.cjium aluminatc, and alumiaum magnesium hydroxide. The alorvastatin formulations can be used to treat medical conditions, including primary hyperc-holesterolemia, dysbetalipoproteinemia, and homozygous familial hypercholesterolemia.
Patent AP-2004003160-A0 (AP)
Title: Tolterodine salts
Inventor: HAWLEY MICHAEL
IPC: A61K31/137
Filed: 2003-04-22
Abstract: The present invention concerns novel pharmaceutically active compounds, pharmaceutical compositions containing the same, the compounds for use as medicaments, and use of the compounds for the manufacture of specific medicaments. The present invention also concerns a method of treatment involving administration of the compounds. Specifically, the compounds are pharmaceutically acceptable salts of tolterodine or hydroxytolterodine, wherein the salt is of an acid selected from the group consisting of aliphatic mono- and dicarboxylic acids comprising from 7 to 24 carbon atoms, alkanedisulfonic acids comprising from 2 to 4 carbon atoms, naphthoic acid derivatives comprising from 11 to 27 carbon atoms, maleic acid and fumaric acid.
Patent CU-22445-A1 (CU)
Title: Obtención de jabón de bano utilizando fangos medicinales o peloides
Inventor: MILIAN RODRIGUEZ CLARA MARIA
Filed: 1995-02-10
Abstract: La presente patente se relaciona con la rama de la jabonería y tiene como finalidad la fabricación de jabones de bano utilizando fangos minero medicinales. La función que logran los fangos en la masa del jabón es, la de imponerle al mismo sus propiedades curativas, de belleza, función esta que logra de una forma más agradable y cumpliendo además con su función de limpieza de la piel. La utilización del fango como un relleno activo en la confección de jabones permite su uso en aquellas patologías y tratamientos de belleza donde el fango es efectivo. Este tipo de jabón puede ser utilizado en patologías tales como acné, pitiriasis versicolor, tina pedis y tina curis, así como de forma profiláctica en mineros bajo tierra que padecen de micosis profesional.
Patent LU-87088-A1 (LU)
Inventor: YURCHENCO JAMES R
IPC: A47C1/024
Filed: 1987-12-22
Abstract: A tilt control arrangement for office furniture chairs of the type having a chair seat structure mounted on a supporting base for rearward and forward tilting movement of the chair seat about an essentially horizontal axis extending essentially crosswise of the seat. The tilt control arrangement comprises a bifurcated seat structure mounting member defining a pair of parallel arms for pivotally mounting the seat structure for its tilting movement. Depending from the underside of the chair seat structure 15 a lug that projects below the level of the chair seat tilt axis. A front to rear extending rod member extends freely through the chair seat lug to have its rear end threadedly engaged with a nut anchored to the chair base, and the rod member having its forward end headed. A resiliently elastomeric cylindrical body is made fast to the rod member only at the rod member head, with the elastomeric body being placed in compression between the rod member head and the seat lug. Compression of the body can be adjusted by rotating the elastomeric body to adjust the tilting resistance of the seat.
Patent LU-88376-A1 (LU)
Inventor: KERGER LEON
IPC: A62C31/02
Filed: 1993-07-12
Abstract: The gun comprises a body (10) with a longitudinal passage (18) and a coupler (19) to be fixed onto a bottle containing the product, as well as a member for opening and closing the passage through the body (10) and the nozzle (12). The opposing front faces of the nozzle (12) and the body (10) comprise concave parts (34, 24), defining a housing for the opening and closing member (14), while the said member (14) is a rotary element capable of pivoting about an axis orthogonal to the axis of the said passage (18) under the action of an external actuating handle (16) against the action of elastic means. The gun is more particularly intended for portable extinguishers. <IMAGE>
Patent MA-37259-A1 (MA)
Title: هندسة ذكية لأنظمة يتم التحكم بها عن طريق شبكة
Inventor: HICHAM MEDROMI
IPC: H04W4/00
Filed: 2014-08-05
Abstract: ،يقترح هذا الإختراع منصة للمراقبة و التحكم في المناطق النووية وتتألف من : لبنة ذكية (6. أنظر الشكل 1) وتتألف مما يلي : مكشاف لتجميع معلومات عن حالة النظام المراقب مكشاف قرب من نوع ليزر يسمح بالتحديد الدقيق لجنبات المحيط حيث يوفر هذا المكشاف أفضل تدقيق زاوي السونار بالموجات فوق الصوتية. تشتغل مشفرات العجلات (عدادات المسافة) بمحركات صغيرة بمعدات معدنية، وعجلة و دعامة للقياس سرعة الدوران وتحديد إتجاه العجلات بطاقة لإلتقاط المعطيات الإحصائية للقياس الإنبعاتات الإشعاعية (الإشعاعات التي يتم قياسها هي إشعاعات من نوع بطاقة لإلتقاط المعطيات المتنقلة لإرسال الإندارات عبر رسائل نصية قصيرة وكيل مسؤول عن جمع المعطيات التي يتم قياسها بالإعتماد على اللبنات الذكية المتنقلة حيث يقوم بفحص مدقق لدراسة إمكانية التدخل للتشحيص المشكل و بالتالي إصدار إنذار
Patent MA-37519-A1 (MA)
Title: Composés et compositions pour inhiber l'activité d'abl1, abl2 et bcr-abl1
Inventor: FURET PASCAL
IPC: C07D403/10
Filed: 2013-05-09
Abstract: La présente invention concerne des composés de formule (i) : dans laquelle y, y
Patent MA-53533-A1 (MA)
Title: Conjugué persistant d'un triple activateur activant le récepteur du glucagon, du glp-1 et du gip
Inventor: JUNG SUNG YOUB
IPC: C07K14/605
Filed: 2018-07-26
Abstract: La présente invention concerne un conjugué persistant d'un triple activateur qui active le récepteur du glucagon, du glp-1 et du gip, et des applications du conjugué persistant.
Patent MA-53782-A1 (MA)
Title: Un équipement de filtrage web à base d’une architecture « client/cloud/ hôte ».
Inventor: ALI SADIQUI
Filed: 2021-07-27
Abstract: L’internet est devenu un outil indispensable pour tout le monde. C’est une sorte d’encyclopédie sans limites. Mais c’est aussi un « univers impitoyable » pouvant devenir menaçant pour les plus vulnérables. Le filtrage web sur internet est devenu un fardeau pour les parents, ou entrepreneurs, soucieux de préserver leurs utilisateurs des multiples dangers qui sévissent sur la toile. Malgré que plusieurs outils de filtrage web soient disponibles sur le marché, leur déploiement et leur configurations rendent cette intégration des fois compliquée voir inefficace. L’idée proposée dans ce document est de développer, en se basant sur des solutions libres, un système de filtrage web léger facile à déployer et à gérer et qui assure à la fois la protection et la surveillance du temps d’utilisation, destiné à un déploiement à domicile ou sur des réseaux de petite envergure.
Patent UY-25484-A1 (UY)
Title: Procedimiento para preparar pirazolopirimidinonas que inhiben la guanosina 3',5'-monofosfato cíclica fosfodiesterasa de tipo 5
Inventor: BUNNAGE MARK E
IPC: A61P35/00
Filed: 1999-04-20
Abstract: Procedimiento para preparar los compuestos de las fórmulas (IA) o (IB): en las que R1 es alquilo opcionalmente sustituido con un grupo heterocíclico unido a N seleccionado entre piperidinilo y morfolinilo; R2 es alquilo; R13 es O-alquilo o NH2; R4 es SO2N-piperazinilo; y las sales farmacéutica o veterinariamente aceptables de los mismos. Dichos compuestos son inhibidores potentes y selectivos de la guanosina 3',5'-monofosfato cíclica fosfodiesterasa de tipo 5 (GMPc PDE5) y tienen utilidad en el tratamiento de, entre otros, la disfunción eréctil en machos (MED) y la disfunción eréctil en hembras (FSD). Ej. no limitante: 5-[2-etoxi-5-(4-etilpiperazin-1-ilsulfonil)piridin-3-il]-3-etil-2-(piridin-2-il)metil-2,6-dihidro-7H-pirazolo[4,3-d]pirimidin-7-ona
Patent UY-26406-A1 (UY)
Title: Aminoácidos bicíclicos como agentes farmacéuticos
Inventor: JUSTIN BRYANS
Filed: 2000-10-19
Abstract: Se refiere a compuestos, sales aceptables farmacéuticamente y prodrogas, de fórmula general: donde n es un entero desde 1 hasta 4, y donde hay estereocentros, que pueden ser independientemente R o S. Comprende ácido (1alfa, 6alfa, 8beta) (2-aminometil-octahidro-inden-2-il) acético; ácido (1alfa, 5beta) (3-aminometil-biciclo(3.1.0)hex-3-il) acético y otros. Se incluye el uso para fabricar composiciones para tratamiento de epilepsia, desmayo, hipoquinesia, artritis, trastornos craneanos, neurovegetativos y neuropatológicos, ansiedad, pánico, dolores y síndrome premenstrual y una composición farmacéutica que comprende dichos compuestos para uso oral,inyección, etc. con dosis diarias de 0,01 mg/kg hasta 100 mg/kg.
Patent UY-29607-A1 (UY)
Title: Compuestos quimicos
Inventor: TORE SKJARET
IPC: A61P3/06
Filed: 2006-06-16
Abstract: Se describen compuestos de fórmula (I): (en donde los grupos variablesson como se definen allí) sales farmacéuticamente aceptables, solvatos, solvatos de dichas sales y profármacos de lso mismos y su uso como inhibidores de la absorción de colesterol para el tratamiento de hiperlipidemia.Se describen también procesos para su fabricación y composiciones farmacéuticas que los contienen.
Patent UY-30283-A1 (UY)
Title: Compuestos de amino-pirimidina 2,6-sustituidos-4-monosustituidos como antagonistas del receptor de prostaglandina d2
Inventor: GARDNER CHARLES J
IPC: A61P37/08
Filed: 2007-04-12
Abstract: Compuestos de amino-pirimidina 2,6-sustituidos-4-monosustituidos de formula (I), donde los radicales R1 y R2 son como se han definido en este documentos, o una sal farmacéuticamente aceptable, hidrato o solvato del mismo, un profármaco farmacéuticamente aceptable del mismo, o una sal farmacéuticamente aceptable, hidrato o solvato del profármaco, una composicion farmacéutica que comprende una cantidad farmacéuticamente eficaz de uno o más compuestos de la invencion mezclada con un vehículo farmacéuticamente aceptable, un método para tratar a un paciente que padece un trastorno mediado por PGD2.
Patent UY-30734-A1 (UY)
Title: Light hub/concentrador de luces
Inventor: GLOODTDOFSKY RAUL
IPC: G05B11/00
Filed: 2007-11-21
Abstract: El producto que se quiere patentar es un concentrador de luces, sirve para controlar en forma remota un número de veinte o menos artefactos eléctricos desde cualquier ordenador con sistena operativo Windows. El producto se conecta al puerto paralelo, luego se conectan los receptores a cada uno de los artefactos eléctricos y está pronto para usarse. De no querer utilizar el software estándar que viene con el producto se puede utilizar el generador de aplicaciones que viene con el mismo para construir una solución de automatización a medida.
Patent UY-31459-A1 (UY)
Title: Paquete para dispositivo dispensador
Inventor: BROOKHOUSE LEN
IPC: A61M15/06
Filed: 2008-11-07
Abstract: Un paquete con envoltura protectora que contiene un dispositivo dispensador, en el cual la envoltura de proteccion comprende al menos un miembro rígido de la envoltura.
Patent ES-183714-A1 (ES)
Title: Mejoras en o relaitvas a empalmes o terminaciones para cables eléctricos de conductores concéntricos
IPC: H01P1/04
Filed: 1948-05-17
Abstract: Mejoras en empalmes para conectar juntas dos longitudes de cables de señalización eléctrica de alta frecuencia de características eléctricas similares comprendiendo un número impar de componentes dispuestos sucesivamente, cuya estructura dieléctrica, de cada uno difiere de la dicho cable, pero es uniforme en toda su longitud, siendo tales las propiedades eléctricas de dichas longitudes de dichos componentes que la suma vectorial de todas las reflexiones que ocurren en las uniones entre componentes sucesivos y entre los componentes extremos y dichas longitudes de cable es esencialmente cero en cualquier punto dentro de dichas longitudes de cable.
Patent ES-192512-A1 (ES)
Title: PROCEDIMIENTO PARA LA ELABORACIoN DE COMPUESTOS VULCANIZABLES
Filed: 1950-03-28
Abstract: Procedimiento para. la elaboración de compuestos vulcanizables empleando un agente de curación que se incorpora íntimamente a un compuesto vulcanizable y calentándose la mezcla caracterizado porque después de efectuada la mezcla se enfría al compuesto a la temperatura ordinaria y más tarde se trabaja de nuevo el compuesto y simultáneamente se moldea.
Patent ES-194636-A1 (ES)
Title: UN APARATO PARA IMPRIMIR MOVIMIENTO BASCULANTE A LAS PIELES QUE POR SUSPENSIoN SON SOMETIDAS A OPERACIONES DE CURTIDO.
Filed: 1950-09-20
Abstract: Aparato para imprimir movimiento basculante a las pieles que por suspensión son sometidas a operaciones de curtido que se caracteriza porque se compone de un cuadro que va suspendido en dos coginetes centrales.
Patent ES-195639-A1 (ES)
Title: UN PROCEDIMIENTO PARA LA PRODUCCIoN DE TIOSEMICARBAZONAS AMINOALCOHILADAS EN EL áTOMO DE AZUFRE, Y SALES DE LAS MISMAS
Filed: 1950-12-01
Abstract: Procedimiento de producir tiosemicarbazonas aminoalkiladas en el átomo de azufre de la fórmula **(Ver fórmula)** donde R1 es un grupo alifático aromático o heterocíclico que puede sustituirse por ejemplo con **(ver fórmula)** o halógeno; R2 es un grupo de la misma clase o hidrógeno; R3 es un grupo alkilámico y R4 y R5 son grupos alkílicos arílicos o aralkílicas o hidrógeno o sales de estos derivados; caracterizado porque una tiosamicarbazona de un aldehido o una cetona se hace reaccionar con un halogenuro aminoalkílico en presencia de una sustancia que combina ácidos con preferencia un alkólxiuro metálico después de lo cual el derivado de una tiosamicarbazona así formado si se quiere se hace reaccionar con un ácido par formar una sal.
Patent ES-262606-A1 (ES)
Title: Improvements relating to the vulcanisation of amorphous polymers and copolymers of alpha-olefins
IPC: C08K5/33
Filed: 1960-11-19
Abstract: Saturated amorphous polymers and copolymers of alpha-olefins with each other and/or with ethylene are vulcanized with the aid of organic percompounds, in the presence of an acid filler, and a quinonic compound of the general formula:- <PICT:0896309/IV (a)/1> or <PICT:0896309/IV (a)/2> in a proportion of 0,01 to 15 parts by weight per 100 parts of polymer. The vulcanization may also be effected in the presence of sulphur. The acid fillers which may be used are those which in aqueous suspension have a pH below 7 such as silica, silicates, kaolin, clay, active earths and channel carbon black. The quinonic compound may be p-benzo-quinondioxime, o,o1-dibenzoyl-p-benzoquinondioxime, or p-nitrosophenol. Exemplified percompounds are cumyl-tert. butyl peroxide, and 2,5-dimethyl-2,5-di(tert. butyl peroxi)-hexane. Examplified copolymers are ethylene-propylene, and ethylenebutene.
Patent ES-268795-A1 (ES)
Title: Process for producing phenol
IPC: C07C37/07
Filed: 1961-07-05
Abstract: Phenol is produced from a crude oxygenated cyclohexane fraction containing cyclohexanone and/or cyclohexanol and other cyclohexane oxidation products, the total amount of cyclohexanone and cyclohexanol being not over 95% by weight of the fraction, by vaporizing the fraction, diluting it with hydrogen in an amount in the range of 1 to 15 mols of hydrogen per mol. of total cyclohexanone and cyclohexanol therein, and contacting the resulting mixture with a dehydrogenation catalyst, such as platinum-on-carbon, at a temperature in the range of 250 DEG to 425 DEG C. at a liquid hourly space velocity in the range of 0.3 to 2.5 per hour. The charge stock is suitably a fraction boiling in the range of 73 DEG C. at 34 mm. Hg. to 205 DEG C. at 6 mm. Hg., the reaction temperature is from 375 DEG to 385 DEG C. and the liquid hourly space velocity 0.7. Phenol having a freezing point of at least 40.0 DEG C. is recovered by fractionating the product under reduced pressure such that the highest temperature is not above 150 DEG C. The charging stock is obtained by air oxidation of cyclohexane in the liquid phase at from 125-180 DEG C., preferably 130 DEG C., in the presence of cobalt naphthenate. The conversion can be 3-16%, preferably 10%. After removal of the unreacted cyclohexane, the desired charge stock is obtained by vacuum distillation. Specifications 929,680 and 939,613 are referred to.
Patent ES-272010-A1 (ES)
Title: Processes of producing tin-nickelphosphorus coatings
IPC: F04B1/20
Filed: 1961-11-15
Abstract: The outer skin of a nickel-phosphorus coating carried by a workpiece, such as the lining of a tank or other hollow container fabricated from one or more steel sheets joined together, is converted to a Sn-Ni-P layer containing 1-50% Sn, 46-93% Ni and 3-12% P by simultaneously depositing metallic tin upon the coating surface, preferably by reducing a compound of tin such as a stannous or stannic chloride or other halide on the surface heated to a temperature between the melting points of tin, e.g. 332 DEG C., and the Ni-P coating, e.g. 880 DEG C., and diffusing the tin into the outer skin, the tin being deposited at a rate not higher than that of diffusing the tin. The reduction may be carried out with reducing gases containing 25-40% by volume hydrogen such as produced by cracking ammonia gas, e.g. at 930 DEG C., or mixing hydrogen and nitrogen, the gases first passing over the tin compound, e.g. SnCl2 heated to 480-500 DEG C., then on to the surface of the heated coating, e.g. at 630 DEG C. Alternatively, cracked natural gas or heated anhydrous ammonia may be used as the gases. With a Ni-P coating of composition 85-97% Ni and 3-15% P, the Sn-Ni-P alloy formed at a reaction temperature of 630 DEG C. during a time of less than 4 hours shows a single layer with a reaction time of 4 hours or longer, three separate intimately bonded layers are formed, namely a first layer bonded to the inner Ni-P alloy portion and consisting of tin distributed in Ni-P alloy, a second layer consisting of Ni-P alloy distributed in tin, and a third layer of tin. The coating is preferably at least 2 mils thick. The initial Ni-P coating may be chemically deposited from a bath of the nickel cation-hypophosphite anion type, or electrodeposited and subsequently heat-hardened, e.g. at 400-630 DEG C. to produce microcrystals of Ni3P dispersed in a matrix of nickel. For chemical deposition the workpiece must be formed of or have growth nuclei of catalytic material such as iron, copper, aluminium or alloys thereof, e.g. steels containing one or more C, Cr, Co, Si, Mn, Ni, Mo, Cu, brass, bronze including Si or P bronze, Be-Cu, Cd-Cu, Ni-Cu, and aluminium brass or bronze. If the workpiece is formed of Mg, Ti, Zr, Hf, it must be first treated by the method disclosed in U.S.A. Specification 2,928,757. U.S.A. Specifications 2,690,401, 2,690,402, 2,717,218, 2,822,294 and 2,908,419 also are referred to.
Patent ES-310819-A1 (ES)
Title: Metal heat insulating structural members
IPC: G21C13/04
Filed: 1965-03-13
Abstract: In a gas-cooled nuclear reactor, the core and heat exchanger are mounted together within a concrete pressure vessel. A shield, separating the core and exchanger, is supported on blocks which thermally insulate the shield from the vessel base. Rollers between the blocks and the shield allow differential dimension charges. The support blocks are of welded steel sheet and have an open structure of vertical and horizontal surfaces, the spaces between which are filled with stainless steel foil.
Patent ES-341815-A1 (ES)
Title: Improvements in or relating to methods of and apparatus for manufacturing Heat Exchanger Tubes
IPC: B23K1/00
Filed: 1967-06-15
Abstract: A heat exchanger tube is made by providing a helix of wire or strip 2 on a multi-layer strip 3 of steel and a copper layer on at least the exterior and heating the assembly to a temperature between the melting-point of copper and steel to braze the layers of the strip together and the wire or strip to the tube. The helix is closely wound and expanded along the tube by a sleeve 4 with a pair of pegs 5, 6 which separate the tuns as the sleeve rotates. The strip for the fin is also multi-layer with a steel core and a layer of copper on each side. The wire may be copper-coated and wetted with flux. Alternatively the wire is uncoated and the outer layer of the tube is made thicker. The helix may be wound directly on to the tube or on to a mandrel (not shown) whose diameter is greater than the tube. The strip or wire is fixed in a slot in the tube before axial expansion by the sleeve 4. The mandrel may be a frusto-conical sleeve rotated at the same speed as the tube during the axial feed of the tube therethrough. The heat exchanger may be zinc-plated after assembly.
Patent ES-353196-A1 (ES)
Title: Chemical treatments for modifying physical properties of various materials
IPC: C03C21/00
Filed: 1968-04-26
Abstract: Method and apparatus for chemically treating glass, e.g., chemical tempering, wherein different areas of the glass are subjected to different treatment. For example, certain areas may be subjected to a stronger treatment than others to provide different areas of the glass with different characteristics.
Patent ES-368837-A1 (ES)
Title: Improvements relating to gas compressors incorporating safety devices
IPC: F04B/
Filed: 1969-06-26
Abstract: A temperature responsive safety device in a gas compressor comprises a valve 20 with inlet holes 24, a spring 30 urging the valve towards its closed position on a seat 18, and a soldered joint 32 holding it open, the solder being chosen to melt at the temperature at which the device is to close, but to form a joint on cooling to hold the valve in its closed position. From the inlets 24 gas passes to outlet holes 13 in the body of the device.